Company profile: Compendia Bioscience
1.1 - Company Overview
Company description
- Provider of cancer genomics solutions for oncology research, including bioinformatics to prioritize and annotate driver variants and link biomarkers to curated knowledge; reporting that connects biomarkers to therapies, guidelines, and clinical trials; targeted NGS assays with PCR-based library prep; liquid biopsy tools using cfDNA/ctDNA/CTCs with digital PCR/NGS; and whole exome sequencing via Ion Proton.
Products and services
- Oncomine Assays: Research-grade targeted NGS assays engineered for oncology research, delivering tools to analyze multiple gene aberrations across various sample types and support multi-gene variant assessment
- Oncomine Informatics: Knowledgebase-driven bioinformatics platform that prioritizes and annotates cancer driver variants, linking biomarkers to a curated knowledgebase to aid cancer research and variant interpretation
- Oncomine Reporter: Guideline-linked reporting tool that produces concise reports connecting cancer biomarkers with public data on therapies, guidelines, and clinical trials for research-facing biomarker context
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Compendia Bioscience
Mindprint Solutions
HQ: Canada
Website
- Description: Provider of software system implementation, serving as the partner that can make the difference, empowering organizations with a highly effective system rather than wasted resources in a failed implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mindprint Solutions company profile →
Research Solutions
HQ: United States
Website
- Description: Provider of full-service document delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Research Solutions company profile →
RadMD
HQ: United States
Website
- Description: Provider of imaging contract research services (iCRO), delivering high-value imaging expertise through 17 staff and over 250 contracted clinical trial readers. Applies market experience and advanced systems to reduce costs and improve efficiency in drug and device development for pharmaceutical/biotech and contract research organisations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RadMD company profile →
Predictive Oncology
HQ: United States
Website
- Description: Provider of AI-driven oncology solutions for pharmaceutical, diagnostic, and biotech industries, including the PEDAL platform for drug-response prediction using a large tumor biobank; 3D tumor models for clinically relevant therapeutic testing; live-tumor drug-response and genomic biomarker testing; formulation services (solubility, stability, optimization) via high-throughput tech; and biologics development, purification, endotoxin detection/removal, and GMP manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Predictive Oncology company profile →
ProKnow
HQ: United States
Website
- Description: Provider of cloud-based software solutions to improve quality in radiation oncology worldwide, delivering a high-impact, low-cost investment in quality, consistency, and improved patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProKnow company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Compendia Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Compendia Bioscience
2.2 - Growth funds investing in similar companies to Compendia Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Compendia Bioscience
4.2 - Public trading comparable groups for Compendia Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →